Skip to main content
. Author manuscript; available in PMC: 2018 Nov 12.
Published in final edited form as: JAMA Ophthalmol. 2016 Aug 1;134(8):897–903. doi: 10.1001/jamaophthalmol.2016.1678

Table 1.

Reported Industry Payments to Physicians Prescribing Anti – VEGF Injections for Ranibizumab and Aflibercept

Payment Type Genentech Regeneron Pharmaceuticals Industry Total
No. of Physicians No. of Payments Payment Amount, $ No. of Physicians No. of Payments Payment Amount, $ No. of Physicians No. of Payments Payment Amount, $
Consultation 50 78 191 753.56 34 56 163 737.25 74 134 355 490.81
Education 67 69 5 902.00 63 82 816.72 129 151 6 718.72
Food and beverage 681 1339 71 680.56 798 1608 64 719.95 1104 2947 136 400.51
Other compensation 37 106 301 926.87 44 129 306 547.55 71 235 608 474.42
Travel 53 180 127 246.96 97 410 86 452.18 136 590 213 699.14
Total 720 1772 698 509.95 827 2285 622 273.65 1144 4057 1 320 783.60

Abbreviation: VEGF, vascular endothelial groeth factor.